Drug Trial Radar · NCT04183166
A Clinical Trial Evaluating TG4050 in Head and Neck Cancer
Last checked: Nov 19, 2026Latest source record: Jan 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
80
Actual
Start
Dec 12, 2019
Primary completion
Dec 30, 2027
Study completion Dec 30, 2031
Sponsor
- Lead sponsor
- TransgeneIndustry
- Sponsor type
- Industry
- First posted
- Dec 3, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, open-label, two arms, randomized, phase I/II study evaluating the safety and tolerability as well as some activity parameters of TG4050 in patients with squamous cell carcinoma of the head and neck (SCCHN).
Conditions
- Squamous Cell Carcinoma of Head and Neck
Interventions
TG4050Drug
Subcutaneous injections weekly for the first 6 weeks and then every 3 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase I: Safety and tolerability (Adverse Event reported per CTCAE v5)Time frame: Up to 2 Years.
- Phase I/II: Disease-Free SurvivalTime frame: Up to 2 years.
Locations
14 sites in 4 countries. Site status is shown where the registry gives one.
Mayo Clinic Jacksonville
Jacksonville, Florida
Hôpital Saint André - CHU de Bordeaux
Bordeaux, France
Hôpital de la Timone
Marseille, France
Institut Curie
Paris, France
IUCT Toulouse
Toulouse, France
Institut Gustave Roussy
Villejuif, France
Hospital Universitari Vall d Hebrón
Barcelona, Spain
Institut Català d Oncologia - Hospital Duran i Reynals
Barcelona, Spain
Hospital Clínico San Carlos
Madrid, Spain
Hospital Universitario La Paz
Madrid, Spain
Hospital Regional Universitario de Málaga - Hospital Civil
Málaga, Spain
Complejo Hospitalario Universitario de Santiago
Santiago de Compostela, Spain
NHS Clatterbridge Cancer Center
Liverpool, United Kingdom
Aintree University Hospital NHS Fondation Trust
Liverpool, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.